Business
Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
SAN DIEGO, June 10, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health,
About this update from Aethlon Medical, Inc.
[{"type":"text","content":"SAN DIEGO, June 10, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a definitive agreement with a single institutional investor for the purchase in a registered direct offering of 1,380,555 shares of its common stock, at a purchase price per share of $9.00, priced at-the-market under Nasdaq rules. \nThe closing of the offering is expected to occur on or about June 14, 2021, subject to the satisfaction of customary closing conditions.\nMaxim Group LLC is acting as the exclusive placement agent for the offering.\nThe gross proceeds to Aethlon, before deducting placement agent fees and other offering expenses, are expected to be approximately $12.425 million. Aethlon intends to use the net proceeds from this offering for working capital and other general corporate purposes.\nThe shares of common stock are being offered by Aethlon pursuant to a \"shelf\" registration statement on Form S-3 that was originally filed on March 19, 2020 and declared effective by the Securities and Exchange Commission (\"SEC\") on March 30, 2020 and the base prospectus contained therein (File No. 333-237269). The offering of the shares of common stock is being made only by means of a prospectus supplement that forms a part of the registration statement. A final prospectus supplement and accompanying base prospectus relating to the shares of common stock being offered will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying base prospectus may be obtained, when available, on the SEC's website at http://www.sec.gov or by contacting Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174, Attention: Syndicate Department, or via email at [email protected] or telephone at (212) 895-3745.\nThis press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.\nCompany Update\nAethlon also announced that on June 9, 2021 it sold 626,000 shares in the open market under its At the Market Offering Agreeme...